Efficacy, safety and patient acceptance of sildenafil citrate as treatment for erectile dysfunction

Journal of Urology

Volumn 164, Issue 4, 2000, Pages 1192-1196

  McMahon, Chris G ^a   Samali, Ramin ^a   Johnson, Helen ^a  

^a Australian Centre for Sexual Health   (Australia)

Author keywords

Coronary disease; Impotence; Penis; Vasodilator agents

Indexed keywords

SILDENAFIL;

ADULT; AGED; ARTICLE; DRUG EFFICACY; DRUG SAFETY; ERECTILE DYSFUNCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT SATISFACTION; PRIORITY JOURNAL; QUALITY OF LIFE; SEXUAL FUNCTION;

EID: 0033811958     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)67139-X     Document Type: Article

References (21)

1. Sexual dysfunction in the United States: Prevalence and predictors
2. Impotence and its medical and psychosocial correlates: Results of the Massachusetts Male Aging Study
3. The epidemiology of erectile dysfunction and its risk factors
4. The effect of age, ethnicity and geographical location on impotence and quality of life
5. Oral sildenafil in the treatment of erectile dysfunction
6. Sildenafil: An orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction
7. Sildenafil citrate (Viagra) in erectile dysfunction: Near normalization in men with broad-spectrum erectile dysfunction compared with age-matched healthy control subjects
8. Clinical efficacy of sildenafil citrate based on etiology and response to prior treatment
9. Indications and early results of sildenafil (Viagra) in erectile dysfunction
10. Comparative results of goal oriented therapy for erectile dysfunction
11. Nonsurgical treatment of cavernosal venous leakage
12. Treatment of intracorporeal injection nonresponse with sildenafil alone or in combination with triple agent intracorporeal injection therapy
13. Sildenafil citrate after radical retropubic prostatectomy
14. Time dependent patient satisfaction with sildenafil for erectile dysfunction (ED) after nerve-sparing radical retropubic prostatectomy (RRP)
15. Clinical safety of oral sildenafil citrate (VIAGRA) in the treatment of erectile dysfunction
16. The rationale for prostaglandin E1 in erectile failure: A survey of worldwide experience
17. Cardiovascular disease risk profiles
18. An analysis of vasculogenic erectile dysfunction as a potential predictor of occult cardiac disease
19. The penile stress test: A window to the hearts of man?
20. ACC/AHA expert consensus document. Use of sildenafil (Viagra) in patients with cardiovascular disease